The 25 references in paper A. Chukhlovin B., YU. Eismont A., V. Dobronravov A., M. Busch V., V. Emanuel L., A. Smirnov V., А. Чухловин Б., Ю. Эйсмонт А., В. Добронравов А., М. Буш В., В. Эмануэль Л., А. Смирнов В. (2014) “Частота и динамика полиомавирусной инфекции после трансплантации почек // Frequency and time dynamics of polyomavirus infection following renal transplantation” / spz:neicon:nefr:y:2014:i:4:p:51-56

1
Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology 2013; 437(2) :63-72
(check this in PDF content)
2
Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, Mihatsch MJ, Thiel G., Mihatsch MJ. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999;67(6):918-922
(check this in PDF content)
3
Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. New Engl J Med 2002; 347(7):488-496
(check this in PDF content)
4
Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005; 5(8):1926-1933
(check this in PDF content)
5
Egli A, Binggeli S, Bodaghi S, Dumoulin A, Funk GA, Khanna N, Leuenberger D, Gosert R, Hirsch HH. Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant 2007; 22 [Suppl 8]: viii72-viii82
(check this in PDF content)
6
Nickeleit V, Mihatsch MJ. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl Int 2006; 19(12): 960-973
(check this in PDF content)
7
Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of polyomaviruses in human disease. Virology. 2009 20; 384(2): 266–273
(check this in PDF content)
8
Husseiny MI, Anastasi B, Singer J, Lacey SF. A comparative study of Merkel cell, BK and JC polyomavirusinfections in renal transplant recipients and healthy subjects. J Clin Virol 2010; 49(2): 137–140
(check this in PDF content)
9
Суханов АВ. Полиомавирусная нефропатия трансплантата. Нефрология и диализ, 2001, 3(4): 411–414
(check this in PDF content)
10
Горбатенко ЕВ, Момыналиев КТ, Грибанов ОГ и др. Полиомавирус (BKV) у реципиентов с трансплантированной почкой (обзор литературы). Нефрология и диализ 2010, 12(3): 164-173
(check this in PDF content)
11
Tan CS, Ellis LC, Wuethrich C, Ngo L, Broge Th A, Jr, Saint-Aubyn J, Miller JS, Koralnik IJ. JC Virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol 2010, 84(18) :9200–9209
(check this in PDF content)
12
Bellizzi A, Nardis C, Anzivino E, Rod o D, Fioriti D, Mischitelli M, Chiarini F, Pietropaolo V. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. J Neurovirol 2012;18(1):1-11
(check this in PDF content)
13
Cheng XS, Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Major EO, Randhawa P, Hardinger KL., Brennan DC. Inhibitory interactions between BK and JC virus among kidney transplant recipients. J Am Soc Nephrol 2011; 22: 825–831
(check this in PDF content)
14
Randhawa PS., Gupta G, Vats A, Shapiro R, Viscidi RP. Immunoglobulin G, A, and M responses to BK virus in renal transplantation Clinical and Vaccine Immunol 2006; 13(9): 1057–1063
(check this in PDF content)
15
Holman CJ, van Burik JAH, Hinrichs SH, Balfour HH, Jr. Specific detection of human BK polyomavirus in urine samples of immunocompromised patients. Clin Diagn Lab Immunol 2003; 10(1): 66–69
(check this in PDF content)
16
Shin SK, Li MS, Fuerst F, Hotchkiss E, Meyer R, Kim TI, Goel A, Boland CR. Oncogenic T-antigen of JC virus is present frequently in human gastric cancers. Cancer 2006; 107:481–488
(check this in PDF content)
17
Seemayer CA., Seemayer NH, Duermueller U, Gudat F, Schaub S, Hirsch HH, Mihatsch MJ. BK virus large T and VP-1 expression in infected human renal allografts. Nephrol Dial Transplant 2008; 23: 3752–3761
(check this in PDF content)
18
Bechert CJ, Schnadig VJ, Payne DA, Dong J. Monitoring of BK viral load in renal allograft recipients by real-time PCR assays. Am J Clin Pathol 2010;133:242-250
(check this in PDF content)
19
Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007; 84(3):323–330
(check this in PDF content)
20
Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single center study. Transplantation 2012;94:814-821
(check this in PDF content)
21
Chatterjee M, Weyandt TB, Frisque RJ. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J. Med. Virol. 2000; 60:353–362
(check this in PDF content)
22
Dörries K, Sbiera S, Drews K, Arendt G, Eggers C, Dörries R.J Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals.Neur ovirol. 2003;9 Suppl 1:81-87
(check this in PDF content)
23
Mertz KD, Junt T, Schmid M, Pfaltz M, Kempf W.I nflammatory monocytes are a reservoir for Merkel cell polyomavirus. J Invest Dermatol. 2010 Apr;130(4):1146-51
(check this in PDF content)
24
Brennan DC, Agha I, Schnitzler MA, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005;5:582-594
(check this in PDF content)
25
Koukoulaki M, Grispou E, Pistolas D, et al. Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 2009;11:1-10 26 Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus
(check this in PDF content)